Skip to main content
Terug
Watch Compare

Evolent Health, Inc.

Datakwaliteit: 100%
EVH
NYSE Services Engineering & Management Services
€ 2,33
▼ € 0,11 (-4,51%)
Marktkapitalisatie: 269,05 M
Prijs
€ 2,41
Marktkapitalisatie
269,05 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 19,90% annually over 5 years — strong growth
Generating 38,84 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 46,46%

Groei

Revenue Growth (5Y)
19,90%
Boven sectorgemiddelde (3,99%)
Revenue (1Y)-26,56%
Earnings (1Y)N/A
FCF Growth (3Y)-47,81%

Kwaliteit

Return on Equity
-61,50%
Onder sectorgemiddelde (-15,85%)
ROIC-15,79%
Net Margin-28,49%
Op. Margin-21,86%

Veiligheid

Debt / Equity
1,26
Boven sectorgemiddelde (0,39)
Current Ratio1,33
Interest Coverage-7,14

Waardering

PE (TTM|2027)
-0,50 | 5,46
Boven sectorgemiddelde (-1,21)
P/B Ratio0,32
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (506 peers)
Metriek Aandeel Sector Mediaan
P/E -0,5 -1,2
P/B 0,3 1,4
ROE % -61,5 -15,8
Net Margin % -28,5 -18,3
Rev Growth 5Y % 19,9 4,0
D/E 1,3 0,4

Koersdoel Analisten

14 analisten
Buy
Huidig
€ 2,33
+122.3%
Koersdoel
€ 5,18
€ 3,00
€ 5,00
€ 8,00
Vooruitzicht
Forward K/W 5,27
Forward WPA € 0,44
WPA Groei (sch.) +157,4%
Omzet Sch. 2,88 B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 € 0,44
€ 0,30 – € 0,73
 2,88 B 11
FY2026 € 0,17
€ 0,10 – € 0,35
 2,49 B 10

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 € 0,05 € 0,08 +62,7%
Q32025 € 0,10 € 0,05 -51,2%
Q22025 € 0,08 -€ 0,10 -223,3%
Q12025 € 0,10 € 0,06 -37,7%

ETFs Holding This Stock

SSETX SSETX
0,71% weight
SSYGX SSYGX
0,71% weight
RUDAX RUDAX
0,54% weight
BOSCX BOSCX
0,54% weight
BOSYX BOSYX
0,54% weight
STSVX STSVX
0,54% weight
MXMTX MXMTX
0,38% weight
FSCC logo FSCC Federated Hermes MDT Small Cap Core ETF
0,20% weight
OASGX OASGX
0,11% weight
OCSGX OCSGX
0,11% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -26,56% Revenue Growth (3Y) 83,69%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 19,90% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,88 B Net Income (TTM) -534,51 M
ROE -61,50% ROA -21,75%
Gross Margin N/A Operating Margin -21,86%
Net Margin -28,49% Free Cash Flow (TTM) 38,84 M
ROIC -15,79% FCF Growth (3Y) -47,81%
Safety
Debt / Equity 1,26 Current Ratio 1,33
Interest Coverage -7,14 Asset Turnover 0,76
Working Capital 140,17 M Tangible Book Value -856,84 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,50 Forward P/E N/A
P/B Ratio 0,32 P/S Ratio 0,14
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 14,44%
Market Cap 269,05 M Enterprise Value 1,21 B
Per Share
EPS (Diluted TTM) -5,07 Revenue / Share 16,81
FCF / Share 0,35 OCF / Share 0,35
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -7,27%
SBC-Adj. FCF -12,92 M Growth Momentum -46,46

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,88 B 2,55 B 556,06 M 382,43 M 907,96 M
Net Income -534,51 M -61,62 M -113,04 M -19,16 M -9,81 M
EPS (Diluted) -5,07 -0,81 -1,28 -0,20 -0,44
Gross Profit — — — — —
Operating Income -410,14 M -40,49 M -71,21 M 3,64 M -42,41 M
EBITDA — — — — —
R&D Expenses — — — — 15,50 M
SG&A Expenses 303,87 M 263,05 M 358,11 M 269,27 M 219,50 M
D&A 115,85 M 118,37 M 123,42 M 67,20 M 60,04 M
Interest Expense 57,47 M 24,72 M 54,21 M 15,57 M 25,43 M
Income Tax -126.000,0 -1,41 M -89,37 M -43,38 M 483.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,90 B 2,54 B 2,68 B 1,82 B 1,42 B
Total Liabilities 1,48 B 1,35 B 1,43 B 957,88 M 725,83 M
Shareholders' Equity 415,19 M 1,00 B 1,07 B 859,42 M 693,63 M
Total Debt 970,54 M 661,99 M 597,05 M 412,99 M 215,68 M
Cash & Equivalents 151,86 M 104,20 M 192,83 M 188,20 M 266,28 M
Current Assets 506,37 M 607,12 M 683,67 M 478,05 M 523,96 M
Current Liabilities 385,26 M 715,50 M 674,24 M 433,44 M 445,49 M